Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone mineralometry in post-menopausal osteoporosis].

R Nuti, G Righi, V Turchetti

    Minerva Medica
    |June 30, 1983
    PubMed
    Summary

    Bone mineralometry accurately assesses bone mass in dysmetabolic diseases like post-menopausal osteoporosis. Treatment with 1.25(OH)2D3 significantly increased bone mineral content in affected women.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Interframe-tunable ultrafast differential-displacement holography.

    The Review of scientific instruments·2024
    Same author

    Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
    Same author

    Recent advances in models for screening potential osteoporosis drugs.

    Expert opinion on drug discovery·2018
    Same author

    Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study.

    Reumatismo·2017
    Same author

    Vertebral Scheuermann's disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
    Same author

    From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.

    International journal of immunopathology and pharmacology·2015

    Area of Science:

    • Endocrinology and Metabolic Diseases
    • Bone Densitometry
    • Gerontology

    Context:

    • Bone mineralometry is crucial for evaluating bone mass in various dysmetabolic conditions.
    • Post-menopausal osteoporosis is a significant focus of densitometric investigation.
    • Reduced bone content is observed in some patients, correlating with age.

    Purpose:

    • To investigate bone mineral content in post-menopausal women using densitometry.
    • To assess the efficacy of 1.25(OH)2D3 in treating bone loss.
    • To explore correlations between bone mass, age, and menopausal duration.

    Summary:

    • A study using a gamma-emitting mineralometer (241Am) on 192 patients revealed reduced bone content, particularly severe in some cases, with a significant correlation between bone mass and age.
    • Thirty-two women with post-menopausal osteoporosis received 1 microgram/day of 1.25(OH)2D3.
    • The treatment resulted in a marked increase in bone mineral content, demonstrating its therapeutic potential.

    Impact:

    • Highlights the effectiveness of 1.25(OH)2D3 in increasing bone mineral content in post-menopausal osteoporosis.
    • Reinforces the role of bone mineralometry in diagnosing and monitoring bone metabolic diseases.
    • Provides insights into the relationship between aging, menopause, and bone density.

    Related Experiment Videos